CASE REPORT
Acute urinary retention in a 14-year-old girl – diagnostic and therapeutic difficulties when initial therapy fails
 
More details
Hide details
1
Medical University of Białystok, Białystok, Poland
 
2
Department of Paediatrics, Immunology, and Nephrology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
 
3
Department of Pediatrics, Nephrology and Immunology, Medical University of Łódź, Łódź, Poland
 
4
Department of Interventional Paediatrics/Paediatric Surgery/Paediatric Urology, Janusz Korczak Paediatric Centre, Regional Multi-Specialist Centre for Oncology and Traumatology of the Nicolaus Copernicus Memorial Hospital, Łódź, Poland
 
5
Department of Developmental Neurology and Epileptology, Polish Mother’s Memorial Hospital Research Institute, Łódź, Poland
 
 
Submission date: 2023-09-15
 
 
Final revision date: 2023-12-16
 
 
Acceptance date: 2023-12-27
 
 
Publication date: 2024-06-06
 
 
Corresponding author
Michał Janusz Łyszkowicz
Medical University of Białystok, Białystok, Poland
 
 
Pediatr Pol 2024;99(2):153-157
 
KEYWORDS
TOPICS
ABSTRACT
Acute urinary retention is rare in children and has various causes, but in 10% of cases has unclear aetiology. It is more common in boys and is often associated with urinary tract inflammation or mechanical obstruction. A 14-year-old girl presented with urinary retention preceded by haematuria and abdominal pain. Catheterisation drained 900 ml of urine, and symptoms initially subsided after taking α-blockers and oxybutynin. However, urinary retention reoccurred and persisted. Cystometry demonstrated bladder insensitivity, decreased detrusor activity, and increased sphincter tone. Suprapubic urinary diversion was performed. Neurological and magnetic resonance imaging examinations were normal, but cerebrospinal fluid showed IgG antibodies that reacted with sulfatide antigens. Immunosuppressive treatment was ineffective. Eventually administration of distigmine and baclofen permanently restored bladder function within a week. Persistent urinary retention is very distressing. Prompt diagnosis is possible, but managing idiopathic cases poses challenges, requiring a multidisciplinary approach. Evaluation based on knowledge of organ innervation is crucial.
REFERENCES (28)
1.
Partin AW, Dmochowski RR, Kavoussi LR, et al. Campbell-walsh-wein urology. 12th ed. Elsevier, Philadelphia 2020, 15408.
 
2.
Yoon PD, Chalasani V, Woo HH. Systematic review and meta- analysis on management of acute urinary retention. Prostate Cancer Prostatic Dis 2015; 18: 297-302.
 
3.
Schmidt AM, Hirsch K, Schroth M, et al. Acute urinary retention in children. J Pediatr Urol 2020; 16: e1-842.e6.
 
4.
Peter JR, Steinhardt GF. Acute urinary retention in children. Pediatr Emerg Care 1993; 9: 205-207.
 
5.
Gatti JM, Perez-Brayfield M, Kirsch AJ, et al. Acute urinary retention in children. J Urol 2001; 165: 918-921.
 
6.
Asgari SA, Mansour Ghanaie M, Simforoosh N, et al. Acute urinary retention in children. Urol J 2005; 2: 23-27.
 
7.
Nevo A, Mano R, Livne PM, et al. Urinary retention in children. Urology 2014; 84: 1475-1479.
 
8.
Agarwal BK, Agarwal N. Acute urinary retention in children. Int Surg J 2017; 4: 1610.
 
9.
Austin P. The role of alpha blockers in children with dysfunctional voiding. ScientificWorldJournal 2009; 9: 880-883.
 
10.
Chopra P, Eliezer D, Deshpande A. Low dose, targeted alpha blockers for refractory bladder dysfunction in children – a single centre experience. J Pediatr Urol 2020; 16: S14.
 
11.
Fisher E, Subramonian K, Omar MI. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev 2014; (6):CD006744.
 
12.
Cain MP, Wu SD, Austin PF, et al. Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol 2003; 170: 1514-1515, discussion 1516-1517.
 
13.
Yucel S, Akkaya E, Guntekin E, et al. Can alpha-blocker therapy be an alternative to biofeedback for dysfunctional voiding and urinary retention? A prospective study. J Urol 2005; 174: 1612-1615, discussion 1615.
 
14.
Lazarus J. Intravesical oxybutynin in the pediatric neurogenic bladder. Nat Rev Urol 2009; 6: 671-674.
 
15.
Han CS, Kim S, Radadia KD, et al. Comparison of urinary tract infection rates associated with transurethral catheterization, suprapubic tube and clean intermittent catheterization in the postoperative setting: a network meta-analysis. J Urol 2017; 198: 1353-1358.
 
16.
Szymański JK, Słabuszewska-Jóźwiak A, Jakiel G. Fowler’s syndrome – the cause of urinary retention in young women, often forgotten, but significant and challenging to treat. Int J Environ Res Public Health 2021; 18: 3310.
 
17.
Karmarkar R, Abtahi B, Saber-Khalaf M, et al. Gynaecological pathology in women with Fowler’s syndrome. Eur J Obstet Gynecol Reprod Biol 2015; 194: 54-57.
 
18.
Legast GM, Lascano AM, Gschwind M, et al. Guillain-Barré and Miller-Fisher overlap syndrome mimicking alimentary botulism. J Clin Neurol Seoul Korea 2017; 13: 442-443.
 
19.
Stoffel JT. Chronic urinary retention in multiple sclerosis patients: physiology, systematic review of urodynamic data, and recommendations for care. Urol Clin North Am 2017; 44: 429-439.
 
20.
Purves D (ed.). Neuroscience. 3rd ed. Sunderland, Mass: Sinauer Associates, Publishers, 2004, 493-495.
 
21.
Yoshimura N, Chancellor MB. Neurophysiology of lower urinary tract function and dysfunction. Rev Urol 2003; 5: S3-10.
 
22.
Kim DK. Current pharmacological and surgical treatment of underactive bladder. Investig Clin Urol 2017; 58: S90-98.
 
23.
Harada T, Fushimi K, Kato A, et al. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity. Biol Pharm Bull 2010; 33: 653-658.
 
24.
Ghanavatian S, Derian A. Baclofen. StatPearls, Treasure Island (FL): StatPearls Publishing 2023.
 
25.
Albright AL. Baclofen in the treatment of cerebral palsy. J Child Neurol 1996 ;11: 77-83.
 
26.
Shirazi M, Jahnabadi Z, Hekmati P. Use of baclofen in children with dysfunctional voiding: a preliminary report. Cent Eur J Urol 2018; 71: 315-319.
 
27.
Rademakers. Detrusor underactivity: from theory to clinical assessment. Maastricht University, 2017.
 
28.
Osman NI, Chapple CR. Are there pharmacotherapeutic options for underactive bladder? Eur Urol Focus. 2018; 4: 6-7.
 
Journals System - logo
Scroll to top